Loading video...
Video Failed to Load
Five sourced findings raise a basic question: are high drug prices funding discovery, or rewarding the companies best positioned to acquire, market, and extend the life of discoveries made elsewhere? Rob Burgess follows the money behind the innovation defense.
110,800 views • 2 months ago •via X (Twitter)
0 Comments
No comments available
Comments from the original post will appear here


